Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization

SIMPLE SUMMARY: The rate of total tumor engraftment of patient-derived xenografts is 50% in cervical cancer. These cancers retain their histopathological characteristics. The gene mutations and expression patterns associated with carcinogenesis and infiltration and the expression levels of genes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto, Shunsuke, Tanaka, Tomohito, Hirosuna, Kensuke, Nishie, Ruri, Ueda, Shoko, Hashida, Sousuke, Terada, Shinichi, Konishi, Hiromi, Kogata, Yuhei, Taniguchi, Kohei, Komura, Kazumasa, Ohmichi, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221029/
https://www.ncbi.nlm.nih.gov/pubmed/35740635
http://dx.doi.org/10.3390/cancers14122969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221029/
https://www.ncbi.nlm.nih.gov/pubmed/35740635
http://dx.doi.org/10.3390/cancers14122969

Ejemplares similares